Insider Trading & Ownership - Keutzer Timothy

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Keutzer Timothy
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-27
Sale
2024-08-29
6:42 pm
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Operating Officer
2,213$1.35$2,988531,837
(Direct)
View
2024-02-02
Sale
2024-02-05
8:53 pm
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Operating Officer
30,971$1.36$42,121534,050
(Direct)
View
2023-08-28
Sale
2023-08-30
4:23 pm
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Development Officer
1,854$1.26$2,336325,290
(Direct)
View
2023-02-02
Sale
2023-02-03
7:43 pm
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Operating Officer
3,394$1.86$6,313327,144
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-01
Option Award
2024-02-05
8:53 pm
N/A
N/A
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Operating Officer
239,731$0534,050
(Direct)
View
2023-02-01
Option Award
2023-02-03
7:43 pm
N/A
N/A
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Operating Officer
265,957$0327,144
(Direct)
View
2022-02-01
Option Award
2022-02-03
4:18 pm
N/A
2032-02-01
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Development Officer
91,204$0117,771
(Direct)
View
2021-08-26
Option Award
2021-08-30
4:15 pm
N/A
N/A
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Development Officer
24,067$026,567
(Direct)
View
2021-02-01
Option Award
2021-02-03
7:52 pm
N/A
2031-02-01
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Development Officer
57,432$057,432
(Direct)
View
2020-02-03
Option Award
2020-02-03
5:28 pm
N/A
2030-02-03
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Development Officer
55,000$055,000
(Direct)
View

Ownership
2020-01-13
4:19 pm
N/A
N/A
Spero Therapeutics Inc.SPROKeutzer Timothy
Chief Development Officer
0$0108,459
(Direct)
View